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ATHEROSCLEROSIS NEEDS SHC
Liu et al. fi  nd that an adaptor protein called Shc orchestrates the response of endothelial cells to stress 
caused by turbulent blood fl  ow.
In endothelial cells, alterations in blood fl  ow are sensed by cell–cell junctions and cell–matrix 
adhesions, which can trigger infl  ammation and the formation of atherosclerotic plaques. The adaptor 
protein Shc, which is expressed in the endothelium, regulates responses to mechanical forces at the 
cell surface, leading the authors to explore its involvement in endothelial infl  ammation.
They now fi  nd that Shc becomes phosphorylated (and activated) primarily in areas of turbulent blood 
fl  ow. Active Shc was found both at cell–cell junctions, in a complex with VE-cadherin and VEGFR2, 
and at cell–matrix adhesions where it associated with integrins in a cadherin-dependent manner. But 
Shc’s arrival at adhesions was delayed for 30 minutes after the onset of shear stress, suggesting that 
signaling from cell–cell contacts may occur fi  rst and control the cell’s interactions with the matrix.
Knockdown of Shc expression with siRNA suppressed signals from both cell–cell junctions and 
adhesions. As the latter signals activate the pro-infl  ammatory transcription factor NF-B, the lack of 
Shc blocked the expression of two NF-B–dependent atherosclerotic genes that encode the leukocyte-
specifi  c adhesion molecules VCAM-1 and ICAM-1. Endothelial cells were therefore unable to bind 
monocytes—the cells that trigger plaque formation when they ingest fat.
The intriguing delay between the appearance of phosphorylated Shc at cell–cell junctions and 
matrix adhesion sites is still unexplained: “We don’t know whether there are two pools of Shc, or 
whether it translocates from cell–cell junctions to adhesions,” says Tzima.
Liu, Y., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200709176.
SUMO KEEPS LAMIN A IN PLACE
A posttranslational defect in nuclear envelope protein lamin A causes it to clump and distort the shape 
of the nucleus, say Zhang and Sarge.
Lamin A forms a structural network that lines the inner surface of the nuclear envelope. Mutations 
in lamin A cause a large number of diseases, such as muscular dystrophy and cardiomyopathy. Now, 
Zhang and Sarge show that two cardiomyopathy-causing mutations prevent post-translational 
modifi  cation of lamin A by SUMO (small ubiquitin-like modifi  er), which leads to its aberrant 
localization both in cell models and diseased human tissue.
The authors focused on the effects of SUMO on lamin A, as a recent yeast two-hybrid screen 
indicated that lamin A binds a sumoylating enzyme. They found that the disease-causing mutations 
within lamin A occurred at residues near its sumolyation site, which prevented SUMO addition.
To understand how defective sumoylation affects lamin A functions, the authors then examined its 
localization. In mouse cardiomyocytes, wild-type lamin A was distributed continuously around the 
nuclear periphery, but mutated lamin A was clumped irregularly. Lamin A was similarly aggregated 
in skin fi  broblasts from a patient with mutation-induced cardiomyopathy, and the nucleus was 
irregularly shaped. In both cell types, mutant lamin A was associated with decreased cell viability.
Altered nuclear shape can disrupt many nuclear processes, including gene expression and DNA 
replication. It is still unclear how these changes, triggered by the absence of SUMO, contribute to 
disease pathogenesis.
Zhang, Y.-Q., and K.D. Sarge. 2008. J. Cell Biol. doi:10.1083/jcb.200712124.
PEGGING MITOCHONDRIAL POSITION
Mitochondria need microtubule-binding proteins for proper positioning, say Chiron et al.
Mitochondria rely on microtubules to move around the cell and for distribution into daughter cells. 
Many cell types use microtubule-bound motors to move mitochondria. Yeast cells instead depend on 
microtubule growth to do the job, but how mitochondria are lashed onto the growing microtubules 
was unknown.
In normal yeast cells, mitochondria are evenly distributed throughout the cell. In a screen of 
temperature-sensitive yeast mutants, the authors discovered one in which mitochondria aggregated at 
the ends of the cell, a phenomenon that also occurs when microtubules depolymerize. The mutant 
gene that caused this phenotype was peg1, which encodes a homologue of the mammalian microtubule 
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plus end–binding protein CLASP.
Mitochondrial aggregation could not be recapitulated by mutants of either the motor protein dy-
nein or other plus end–binding proteins. The Peg1 mutation did not affect the cytoskeleton, and the 
changes were independent of the cell cycle, suggesting the aggregation was not due to other changes 
in microtubules.
Peg1 was found to be a mitochondrial peripheral membrane protein. As CLASP links membranes 
to microtubules in mammalian cells, Chiron proposes a similar function for Peg1 in yeast, and sug-
gests that it hitches mitochondria to microtubules.
Chiron, S., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200712147.
ACTIN AND MYOSIN IN THE MITOTIC SPINDLE
Cables of actin stretch from pole to pole of the mitotic spindle, and, with myosin, help control spindle 
length and shape, according to Woolner et al.
Microtubules and their motors are indispensible for mitotic spindle formation, but whether actin 
fi  laments and actin-based myosin motors are also part of the spindle apparatus is a controversial issue. 
Mitotic spindles interact with cortical actin, which is thought to anchor them. One protein that might 
be mediating this interaction is Myo10, an unconventional myosin that can bind both actin and 
microtubules. Because Myo10 is important for meiotic spindle formation, the authors sought to 
defi  ne its function in mitotic spindles.
They now fi  nd that knockdown of Myo10 leads to longer spindles, and fragmented star-shaped 
spindle poles. In the absence of Myo10, spindle rotation movements were slow and smooth rather 
than quick and jerky. The normally spasmodic spindle movement suggests that Myo10 anchors the 
spindle by forming brief, transient links with cortical actin.
Rescue experiments indicated that Myo10 has both actin-dependent and -independent functions 
during mitosis. Spindle pole fragmentation was rescued by Myo10 that lacked the actin-binding head 
domain. However, the long-spindle defect required the actin-binding region, or could be suppressed by 
disrupting actin, suggesting that actin helps elongate the spindle, whereas Myo10 shortens it.
As Myo10’s actin-binding domain was required for normal spindle length, the authors sought 
actin in the spindle. Live cell imaging showed dynamic actin cables within mitotic spindles, 
oriented longitudinally and rotating along with the spindle as a whole, “as if the cables helped 
determine the direction of spindle motion,” says Woolner. The mechanism for coordination of actin 
and Myo10 is still unclear, but the authors envision Myo10 “walking along the actin, holding the 
poles at a fi  xed point.”
Woolner, S., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200804062.
NUCLEOPHOSMIN MUTATION IS DOUBLE TROUBLE
Bonetti et al. fi  nd that mutations in a nucleolar chaperone destroy a tumor suppressor and 
simultaneously activate an oncogene.
Mutations in the nucleolar chaperone nucleophosmin (NPM) are a major cause of acute 
myelogenous leukemia. One way NPM mutations cause cancer is by failing to sequester the tumor 
suppressor Arf in the nucleolus, thus allowing its degradation in the cytoplasm. Bonetti and colleagues 
now show that mutant NPM has the same effect on another protein called Fbw7-, which suppresses 
the oncogenic protein c-Myc.
Fbw7- ubiquitinates c-Myc and promotes its degradation, thus lowering the levels of this powerful 
transcription factor. In cells lacking functional NPM, the authors showed that Fbw7- partially 
relocalized to the cytoplasm and was degraded. As a consequence, the half-life of c-Myc doubled in 
NPM mutant-bearing cells, and the total amount of c-Myc rose. Cytoplasmic Fbw7- could not 
prevent c-Myc from promoting tumors in culture. This loss of Fbw7- regulation of c-Myc could be 
mitigated by blocking nuclear export.
Mutant NPM still bound to Fbw7-, but was unable to retain it in the nucleolus. The authors think 
that the chaperone activity of normal NPM ensures proper folding of its binding partners and helps 
prevent their degradation by retaining them in the nucleolus.
Bonetti, P., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200711040.
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